Ann: FDA grants broader orphan drug status to PTX100 for TCLs, page-29

Still 28% below the very recent CR price of 17.5c. I saw this on IMU with their last 2-3 announcements. I sold out at 17.5 on them a while ago and each time I saw an announcement I thought, "Damn. Missed the boat." only to see the SP just groan a cent or so higher before giving it all back up again in the following days; the news swallowed like blood poured on sand.

There's some sort of leeriness or lethargy in the biospec sectors generally. Call it the madness of crowds or whatever. Old habits die hard and so tech is still dominating all the news cycles like a Hollywood celebrity and whoever gets the eyeballs gets the money. See how all the brouhaha about the Metaverse has been completely memory-holed as Meta moves to quietly dump it? But the media just switches right over to the next hot fad. Meanwhile Joe Biden's big PR push on the cancer moonshot has completely evaporated. As Keynes said, the stock market is a beauty contest.

The pending news on PTX100 would be a big factor forestalling big influxes atm but the volume is still 5-8x the recent average so let's put the wins under the belt and push on. If results are even reasonably good, we should be back well over the CR price of 17.5c.